RANZCOG strongly supports long-acting contraceptives

13 December 2017

Media Statement

A report in the media from the ABC regarding long-acting reversible contraception (LARC) shows a lack of perspective on the risks and benefits of the Implanon and Mirena contraceptive methods.
Large patient trials have demonstrated that these devices are very safe and effective at preventing pregnancy. When women are followed up for a year after starting one of these methods, the majority are happy with their choice and continue to use it.
The figures of adverse events quoted by the ABC demonstrate how uncommon any major complications are – affecting less than one in a thousand women.  
“Women should be given balanced advice about the advantages and disadvantages of the different contraceptive methods in order to make an informed choice,” said RANZCOG spokesperson, Associate Professor Kirsten Black.
“Part of the information healthcare professionals provide should make it clear that LARC methods are significantly more effective than many others in preventing unplanned pregnancies,” continued Professor Black.
The body of evidence in favour of the use of long-acting contraceptive methods is so strong that governments in the United States and the United Kingdom as well as numerous professional organisations across the world, including the World Health Organization, have recommended greater availability of LARC.
“The article from the ABC does a great disservice to women by presenting an unbalanced approach that is not based on facts and is contrary to the opinion of world leaders in this field,” said Professor Black.
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists fully supports the Consensus Statement facilitated by the Australian Healthcare and Hospitals Association (AHHA) on LARC.



Dr Pieter Mourik (AM)

Being recognised in the Australia Day honours was a highlight for this rural medicine advocate.



RANZCOG urges all practitioners to help pregnant women get vaccinated

RANZCOG urges all practitioners to heed the advice issued by RANZCOG and ATAGI which recommends that pregnant women are routinely offered Pfizer or Moderna mRNA vaccine at any stage of pregnancy.



EOI: eLearning content reviewers

As women’s healthcare evolves rapidly, RANZCOG is keen to ensure its eLearning programs and modules meet member expectations and education standards.